2022
DOI: 10.1016/bs.ampbs.2022.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial AB toxins and host–microbe interactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
2

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(10 citation statements)
references
References 148 publications
0
10
0
Order By: Relevance
“…In this regard, our study indicates that the glycan receptor binding PltB of ToxoidVac and PltBVac appears to effectively stimulate humoral immune responses leading to the production of typhoid toxin-neutralizing antibodies. This observation is not too surprising, as some toxoids are being used as adjuvants of human vaccines, such as tetanus toxoid for typhoid vaccine [9], while many others have also been demonstrated to be efficacious against various bacterial, viral, and parasitic pathogens [9, 36-39]. Furthermore, when the same concentrations of these two subunit vaccines were used, ToxoidVac elicited stronger humoral immune responses for anti-PltB antibodies than PltBVac (Fig.…”
Section: Discussionmentioning
confidence: 97%
“…In this regard, our study indicates that the glycan receptor binding PltB of ToxoidVac and PltBVac appears to effectively stimulate humoral immune responses leading to the production of typhoid toxin-neutralizing antibodies. This observation is not too surprising, as some toxoids are being used as adjuvants of human vaccines, such as tetanus toxoid for typhoid vaccine [9], while many others have also been demonstrated to be efficacious against various bacterial, viral, and parasitic pathogens [9, 36-39]. Furthermore, when the same concentrations of these two subunit vaccines were used, ToxoidVac elicited stronger humoral immune responses for anti-PltB antibodies than PltBVac (Fig.…”
Section: Discussionmentioning
confidence: 97%
“…In this regard, our study indicates that the glycan receptor binding PltB of ToxoidVac and PltBVac appears to effectively stimulate humoral immune responses leading to the production of typhoid toxin-neutralizing antibodies. This observation is not too surprising, as some toxoids are being used as adjuvants of human vaccines, such as tetanus toxoid for typhoid vaccine [ 9 ], while many others have also been demonstrated to be efficacious against various bacterial, viral, and parasitic pathogens [ 9 , 36 39 ]. Furthermore, when the same concentrations of these two subunit vaccines were used, ToxoidVac elicited stronger humoral immune responses for anti-PltB antibodies than PltBVac ( Fig 1 ).…”
Section: Discussionmentioning
confidence: 99%
“…Many bacterial protein toxins are active through enzymatic activity and contain an enzymatic (A) domain or subunit. These toxins are referred to as AB toxins [ 29 ]. Intracellularly active toxins have additional domains, namely the translocation (T) domain, which facilitates the passage of the A domain into the cytosol, and the autoprocessing domain involved in the release of the A domain from the B domain.…”
Section: Diversity In Bacterial Protein Toxinsmentioning
confidence: 99%
“…Most of the multiprotein AB toxins retain a complex structure, for example, one A subunit and five B subunits assembled in a pentamer (AB 5 : cholera toxin (CT), shiga toxin (ST)), two distinct A subunits and five B subunits (A 2 B 5 , typhoid toxin (TyT)), one A, and two B subunits (AB 2 , cytolethal distending toxin (CDT)). Pertussis toxin (PTX) has an AB 5 structure with four distinct proteins in the B pentamer [ 29 ] ( Figure 3 ).…”
Section: Diversity In Bacterial Protein Toxinsmentioning
confidence: 99%
See 1 more Smart Citation